HomeComparePUTKY vs ABBV

PUTKY vs ABBV: Dividend Comparison 2026

PUTKY yields 6.72% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PUTKY wins by $34949.03M in total portfolio value
10 years
PUTKY
PUTKY
● Live price
6.72%
Share price
$37.18
Annual div
$2.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34949.13M
Annual income
$33,978,372,579.30
Full PUTKY calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — PUTKY vs ABBV

📍 PUTKY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPUTKYABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PUTKY + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PUTKY pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PUTKY
Annual income on $10K today (after 15% tax)
$571.54/yr
After 10yr DRIP, annual income (after tax)
$28,881,616,692.41/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, PUTKY beats the other by $28,881,595,636.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PUTKY + ABBV for your $10,000?

PUTKY: 50%ABBV: 50%
100% ABBV50/50100% PUTKY
Portfolio after 10yr
$17474.62M
Annual income
$16,989,198,675.53/yr
Blended yield
97.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

PUTKY
No analyst data
Altman Z
2.9
Piotroski
7/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PUTKY buys
0
ABBV buys
7
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-18
Julia Letlow🏢 House$ABBV▼ Sell$1,001 - $15,0002025-12-08
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-11-13
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-31
Lisa McClain🏢 House$ABBV▼ Sell$1,001 - $15,0002025-10-30
Lisa McClain🏢 House$ABBV▲ Buy$1,001 - $15,0002025-10-30
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-22
Julie Johnson🏢 House$ABBV▼ Sell$1,001 - $15,0002025-08-14
John Boozman🏛 Senate$ABBV▼ Sell$1,001 - $15,0002025-08-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPUTKYABBV
Forward yield6.72%3.06%
Annual dividend / share$2.50$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.6%
Portfolio after 10y$34949.13M$102.3K
Annual income after 10y$33,978,372,579.30$24,771.77
Total dividends collected$34882.29M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PUTKY vs ABBV ($10,000, DRIP)

YearPUTKY PortfolioPUTKY Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$12,045$1,344.81$11,550$430.00+$495.00PUTKY
2$15,916$3,027.66$13,472$627.96+$2.4KPUTKY
3$24,508$7,477.84$15,906$926.08+$8.6KPUTKY
4$47,746$21,522.81$19,071$1,382.55+$28.7KPUTKY
5$129,464$78,375.68$23,302$2,095.81+$106.2KPUTKY
6$535,754$397,228.05$29,150$3,237.93+$506.6KPUTKY
7$3,645,840$3,072,582.63$37,536$5,121.41+$3.61MPUTKY
8$42,983,493$39,082,444.06$50,079$8,338.38+$42.93MPUTKY
9$907,247,946$861,255,608.59$69,753$14,065.80+$907.18MPUTKY
10$34,949,127,881$33,978,372,579.30$102,337$24,771.77+$34949.03MPUTKY

PUTKY vs ABBV: Complete Analysis 2026

PUTKYStock

PT United Tractors Tbk, together with its subsidiaries, sells and rents heavy equipment in Indonesia. The company operates through six segments: Construction Machinery, Mining Contracting, Coal Mining, Gold Mining, Construction Industry, and Energy. It also distributes heavy equipment under the Komatsu, UD Trucks, Scania, Bomag, and Tadano names to mining, plantation, construction, and forestry sectors, as well as for industrial heavy equipment. In addition, it sells and leases tractors, generators, forklifts, and mini excavators, as well as sells commodity parts. Further, the company offers mining services that supports coal companies, such as mining design and implementation, preliminary assessment and feasibility studies, construction of infrastructure and plant, removal of overburden and waste, commercial production, expansion of mine/plant, reclamation and revegetation, and transshipment and marketing, as well as owns interests in various coal mine concessions with total estimated coal reserves of 63 million tons, as well as technical and construction services for building, civil, and maritime work. Additionally, it engages in the engineering, planning, assembling, and manufacturing components of machinery, tools, parts, and heavy equipment; provision of vessel construction and related repair services; provision of vessel charter and shipping, and reconditioning services for engines and components; operating power plants; concrete product businesses; fishery business; exploration, mining, and mineral processing of gold and silver; and manufacturing of heavy equipment components and attachments. The company was founded in 1972 and is headquartered in Jakarta Timur, Indonesia. PT United Tractors Tbk is a subsidiary of PT Astra International Tbk.

Full PUTKY Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this PUTKY vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PUTKY vs SCHDPUTKY vs JEPIPUTKY vs OPUTKY vs KOPUTKY vs MAINPUTKY vs JNJPUTKY vs MRKPUTKY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.